CVS Health Corporation

CVS Health Corporation is an American integrated healthcare company that operates a leading pharmacy chain, one of the nation's largest pharmacy benefits managers (Caremark), and the health insurer Aetna, generating $402.1 billion in revenue in fiscal 2025. With roughly 9,000 retail pharmacies, a PBM covering approximately 87 million lives, and a health benefits arm serving more than 37 million people, CVS Health touches nearly every corner of the US healthcare system.

This is a story about whether vertical integration in healthcare creates durable economic advantages or merely assembles adjacent low-margin businesses under one roof. The company absorbed Aetna in 2018 for $69 billion, spent another $18 billion on Oak Street Health and Signify Health in 2023, and now carries roughly $94 billion in total debt. In the three years since, the Aetna acquisition has swung from a profit center to a near-break-even operation and is now halfway through a margin recovery effort; the PBM is navigating a regulatory reset that could redefine its economics; and the retail pharmacy business is steadily losing margin to reimbursement pressure. The file turns on a single question: whether the sum of CVS Health's parts can produce a return on the ~$87 billion it invested in the Aetna and care-delivery acquisitions before the constituent businesses face structural erosion that no amount of synergy can offset.

The stock tells a story of its own. At $100 per share in June 2026, the market capitalisation of roughly $128 billion represents about 8.5 times the midpoint of 2026 adjusted operating income guidance — a multiple that implies the market sees an improving earnings trajectory but remains sceptical about the terminal value of a conglomerate whose largest segments all face meaningful headwinds. CVS Health is, at this price, neither obviously cheap nor obviously expensive. It is a bet on execution.